Summary & Overview
HCPCS Level II G0460: Autologous PRP for Non-Diabetic Chronic Wounds
HCPCS Level II code G0460 denotes the use of autologous platelet-rich plasma (PRP) or other blood-derived products for treatment of non-diabetic chronic wounds and ulcers, encompassing phlebotomy, preparation, administration, and dressing per treatment. This code matters nationally as biologic therapies for chronic wounds are increasingly used to address complex, hard-to-heal wounds and to standardize billing for bundled preparation and application services. Clear coding affects coverage determinations, provider reimbursement, and patient access to these therapies.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and service definitions, national coverage patterns and benchmark considerations where available, common billing modifiers, and policy implications relevant to outpatient wound care providers and payers. The publication outlines how G0460 is used to capture the full treatment episode per application and summarizes administrative elements that influence claims processing and payer review.
This summary aids clinicians, billing professionals, and payers in understanding the code’s scope, typical sites of service, and the kinds of documentation and coding practices that commonly accompany use of autologous blood-derived products for non-diabetic chronic wounds.
Billing Code Overview
HCPCS Level II code G0460 describes autologous platelet rich plasma or other blood-derived product used for treatment of non-diabetic chronic wounds or ulcers. The code includes all preparatory and administration steps as described: phlebotomy, centrifugation or mixing, preparatory procedures, administration, and dressings, per treatment.
Service Type: Biologic wound therapy with autologous blood-derived products
Typical Site of Service: Outpatient clinics, wound care centers, ambulatory surgical centers, and other outpatient settings where wound treatments are performed
Clinical & Coding Specifications
Clinical Context
A 67-year-old patient with a chronic non-healing venous leg ulcer present for 6 months despite standard wound care (compression therapy, debridement, topical dressings) presents to an outpatient wound care clinic. The wound measures 3.0 x 2.5 cm with granulation tissue but stalled healing. After clinical assessment and documentation of prior therapies and wound measurements, the treating clinician recommends autologous platelet-rich plasma (PRP) application. The clinical workflow includes informed consent, phlebotomy for autologous blood draw, centrifugation and preparation of the platelet-rich product in a sterile field, wound bed preparation and any necessary debridement, application of the PRP or blood-derived product to the wound, and placement of an appropriate dressing. The procedure is performed during an outpatient clinic visit or ambulatory surgical center encounter. Post-treatment instructions and scheduled wound follow-up visits for dressing changes and reassessment are documented. Billing uses G0460 per treatment, with documentation of diagnosis, prior conservative care, procedure steps (phlebotomy, centrifugation, application), and any supplies or dressings used.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no other applicable modifier applies to the claim. |